Table 1.
General demographic data and clinical characteristics of the three groups
| Effect | FEP (n = 48) | CHR (n = 24) | Healthy controls (n = 42) | F/χ2 | P-value |
|---|---|---|---|---|---|
| Age (years) | 15.06 ± 1.69 | 13.95 ± 1.97 | 14.23 ± 2.18 | 7.019 | 0.030a |
| Gender, % (n) | 1.479 | 0.477 | |||
| Male | 39.60% (19) | 45.80% (11) | 52.40% (22) | ||
| Female | 60.40% (29) | 54.20% (13) | 47.60% (20) | ||
| Duration of illness (months) | 4 (7.75, 2.25) | 4 (8.00, 2.00) | − | 0.167 | 0.868 |
| PANSS score | |||||
| Positive symptoms | 20.05 ± 5.14 | 15.13 ± 4.24 | − | 3.285 | 0.002 |
| Negative symptoms | 20.26 ± 6.93 | 16.60 ± 5.61 | − | 1.821 | 0.074 |
| General pathology symptoms | 41.58 ± 8.90 | 27.87 ± 6.58 | − | 5.398 | <0.001 |
| SOPS score | |||||
| Positive | − | 10.93 ± 2.46 | − | ||
| Negative | − | 11.40 ± 2.59 | − | ||
| Disorganization | − | 9.80 ± 2.21 | − | ||
| General | − | 7.40 ± 0.99 | − | ||
| Correct response rates | 93.80% ± 8.89% | 95.54% ± 3.17% | 96.58% ± 1.87% | 2.412 | 0.094 |
Data are represented as the mean ± s.d. or median (third quartile, first quartile). FEP, first-episode psychosis; CHR, clinical high risk; PANSS, Positive and Negative Syndrome Scale; SOPS, Scale of Psychosis-Risk Syndromes.
a.
Post hoc tests showed no statistically significant difference.